SP3 and lung carcinoma: Only few direct transcriptional regulators of DNMT3B such as SP1, SP3 or FOXO3A [46, 47] have been identified and only few that are known have such a clear and important link to cancer (for example, FOXO3A negatively regulates DNMT3B promoter activity in lung cancer [47]).